Resources

Products
- For Providers
- For Life Sciences
Platform
Company
Resources
Press
- Media InsightRX in the news — digital, print, podcasts, and other outlets
- Press Releases Announcements for events, partnerships, and company updates

FEATURED POST

InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution

Search Blog section Author Tags

Thought Leadership

Dec 3, 2024

NCA vs. MAP Bayesian estimation for dose adjustment of busulfan and other medications

Thought Leadership

Sep 18, 2024

How well do AUC24 estimates and trough estimates correlate in vancomycin?

Product Innovation

Sep 11, 2024

Choosing the right model for your patient: An introduction to InsightRX Gemini

Thought Leadership

Oct 12, 2023

Using hybrid PKPD/ML models to accurately predict risk of neutropenia

Thought Leadership

Jul 3, 2023

How Clinical Decision Support for Precision Dosing Can Enhance Healthcare Equity and Inclusion

Maximize therapeutic success with precision medicine.

What We Do

For Providers

Bayesian Dosing (MIPD)
Real-Time Dosing Analytics
Available Drug Modules

For Life Sciences

Precision Dosing in Clinical Trials
PKPD Analytics in Clinical Trials
Companion Applications

How We Do It

Continuous Learning
Integrations
Security & Regulatory
Success & Support
Data Science

Information

Product Innnovation
Scientific Publications
Thought Leadership
White Papers
How to Cite InsightRX

Press

Media
Press Releases

About

Contact Us
Customers
Leadership
Advisory Board
Mission & Vision
Careers

548 Market Street
#88083
San Francisco, CA 94104

View our privacy policy

InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance

FEATURED POST

NCA vs. MAP Bayesian estimation for dose adjustment of busulfan and other medications

How well do AUC24 estimates and trough estimates correlate in vancomycin?

Choosing the right model for your patient: An introduction to InsightRX Gemini

Using hybrid PKPD/ML models to accurately predict risk of neutropenia

How Clinical Decision Support for Precision Dosing Can Enhance Healthcare Equity and Inclusion

What We Do

For Providers

For Life Sciences

How We Do It

Information

Resources

Press

About

548 Market Street#88083San Francisco, CA 94104

548 Market Street#88083San Francisco, CA 94104

548 Market Street
#88083
San Francisco, CA 94104

548 Market Street
#88083
San Francisco, CA 94104